Dr. Andrew Saxon, MD

• Addiction Psychiatry

• Psychiatry

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of Washington

  Residency Hospital

• La Co Usc Medical Center

  Internship Hospital

• Tufts University School Of Medicine

  Medical School

• Patient-centered primary care for adults at high risk for AUDs: the Choosing Healthier Drinking Options In primary CarE (CHOICE) trial, 2017-05-17

• Rationale, design and methods of VA-BRAVE: a randomized comparative effectiveness trial of two formulations of buprenorphine for treatment of opioid use disorder in veterans, 2022-01-31

• A Pilot Trial of Prazosin, an Alpha-1 Adrenergic Antagonist, for Comorbid Alcohol Dependence and Posttraumatic Stress Disorder, 2015-04-01

• Secondary Analysis of Pain Outcomes in a Large Pragmatic Randomized Trial of Buprenorphine/naloxone Versus Methadone for Opioid Use Disorder, 2020-01-15

• Factors affecting willingness to provide buprenorphine treatment, 2008-08-20

• Mood Disorders and Risk of Lung Cancer in the EAGLE Case-Control Study and in the U.S. Veterans Affairs Inpatient Cohort, 2012-08-07

• Integrating Opioid Use Disorder Treatment Into Primary Care Settings Integrating Opioid Use Disorder Treatment Into Primary Care Settings, 2023-08-11

• Accessibility to Medication for Opioid Use Disorder After Interventions to Improve Prescribing Among Nonaddiction Clinics in the US Veterans Health Care System Accessibility to Opioid Use Disorder Medication in the US Veterans Health Care System, 2021-12-06

• Clinical documentation of patient-reported medical cannabis use in primary care: Towards scalable extraction using natural language processing methods, 2022-05-13

• Harm reduction with pharmacotherapy for homeless people with alcohol dependence: Protocol for a randomized controlled trial, 2014-05-17

• Medication-assisted treatment for opioid addiction: methadone and buprenorphine, 2013-12-27

• Study Results from the Clinical Trials Network's First Ten Years: Where Do They Lead?, 2010-02-18

• Combining extended-release naltrexone and behavioral harm-reduction treatment for people experiencing homelessness and alcohol use disorder: A Randomized Clinical Trial, 2021-03-10

• Non-pharmacological Treatment for Chronic Pain in US Veterans Treated Within the Veterans Health Administration: Implications for Expansion in US Healthcare Systems, 2022-01-19

• Elevated customary alcohol consumption attenuates opioid effects, 2021-11-04

• Proceedings of the 3rd Biennial Conference of the Society for Implementation Research Collaboration (SIRC) 2015: advancing efficient methodologies through community partnerships and team science Seattle, WA, USA. 24-26 September 2015, 2016-06-23

• Prevalence and Treatment of Opioid Use Disorders among Primary Care Patients in Six Health Systems, 2019-11-15

• Double-blind Randomized Clinical Trial of the a-1 Noradrenergic Antagonist Prazosin for Alcohol Use Disorder, 2018-08-29

• Prevalence of Alcohol Misuse and Follow-Up Care in a National Sample of OEF/OIF VA Patients With and Without TBI, 2016-08-01

• Survey of Primary Care and Mental Health Prescribers' Perspectives on Reducing Opioid and Benzodiazepine Co-prescribing Among Veterans, 2017-03-01

• Clinical leaders and providers' perspectives on delivering medications for the treatment of opioid use disorder in Veteran Affairs' facilities, 2021-09-06

• Commentary on Burns et al. (2015): Retention in Buprenorphine Treatment, 2015-02-14

• Specific polysubstance use patterns predict relapse among patients entering opioid use disorder treatment, 2022-12-05

• Prevalence and correlates of cannabis use and cannabis use disorder in United States veterans: Results from the National Epidemiologic Survey on Alcohol and Related Conditions (NESARC-III), 2021-08-19

• Comparing mental and physical health of U.S. veterans by VA healthcare use: implications for generalizability of research in the VA electronic health records, 2022-12-09

• Acceptability and feasibility of a mobile health application for video directly observed therapy of buprenorphine for opioid use disorders in an office-based setting, 2020-01-10

• Receipt of medications for opioid use disorder among youth engaged in primary care: data from 6 health systems, 2021-07-07

• Buprenorphine therapy for opioid addiction in rural Washington: The experience of the early adopters, 2014-03-31

• Trends in Prescriptions for Non-opioid Pain Medications Among U.S. Adults With Moderate or Severe Pain, 2014-2018, 2022-02-08

• Medication-assisted therapy for opioid addiction, 2014-06-13

• Is telemedicine the answer to rural expansion of medication treatment for opioid use disorder? Early experiences in the feasibility study phase of a National Drug Abuse Treatment Clinical Trials Network Trial, 2021-04-20

• Introduction to the Special Series: National Drug Abuse Treatment Clinical Trials Network and the Opioid Use Disorder Care Continuum-20 years of research informing practice, 2022-02-02

• Trends in Cannabis Use Disorder Diagnoses in the U.S. Veterans Health Administration: 2005-2019, 2022-07-28

• Pain, cannabis use, and physical and mental health indicators among veterans and non-veterans: results from National Epidemiologic Survey on Alcohol and Related Conditions-III, 2022-02-01

• Effects of Buprenorphine Dose and Therapeutic Engagement on Illicit Opiate Use in Opioid Use Disorder Treatment Trials, 2022-03-30

• State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019 State Cannabis Legalization and Cannabis Use Disorder in the US Veterans Health Administration, 2005 to 2019, 2023-03-01

• New Coprescription of Opioids and Benzodiazepines and Mortality Among Veterans Affairs Patients With Posttraumatic Stress Disorder, 2019-07-09

• Preliminary Findings: Contingency Management Targeting Psycho-Stimulant Use Results in Secondary Decreases in Smoking for Severely Mentally Ill Adults, 2013-09-13

• Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial, 2021-06-22